SLAMF7-directed Immunostimulatory Antibody [EPC] - N0000192338

Pharmacologic Class Information

Pharmacologic Code N0000192338
Pharmacologic Name SLAMF7-directed Immunostimulatory Antibody
Pharmacologic Uses
  • SLAMF7-directed immunostimulatory antibody
Pharmacologic Concept Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions:
  • A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication.
  • A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

NDC Products with SLAMF7-directed Immunostimulatory Antibody

The table contains 2 products whose active ingredient are classified under the same pharmacologic class SLAMF7-directed Immunostimulatory Antibody [EPC].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0003-2291Empliciti Non-Proprietary Name: ElotuzumabInjection, Powder, Lyophilized, For SolutionIntravenousE.r. Squibb & Sons, L.l.c.ACTIVE
0003-4522Empliciti Non-Proprietary Name: ElotuzumabInjection, Powder, Lyophilized, For SolutionIntravenousE.r. Squibb & Sons, L.l.c.ACTIVE